Translational highlights in breast cancer research and treatment: recent developments with clinical impact
Purpose of reviewOver the last decades the time which is needed to translate a preclinical finding or idea in the clinic has reduced continuously. Especially but not only for breast cancer the number of tested drugs and targeted pathways have increased immensely. In addition, the introduction of imm
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2019/02/01
|
| In: |
Current opinion in obstetrics and gynecology
Year: 2019, Jahrgang: 31, Heft: 1, Pages: 67-75 |
| ISSN: | 1473-656X |
| DOI: | 10.1097/GCO.0000000000000510 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1097/GCO.0000000000000510 |
| Verfasserangaben: | Peter A. Fasching, Andreas Schneeweiss, Hans-Christian Kolberg, Johannes Ettl, Tanja Fehm, Friedrich Overkamp, and Diana Lüftner |
| Zusammenfassung: | Purpose of reviewOver the last decades the time which is needed to translate a preclinical finding or idea in the clinic has reduced continuously. Especially but not only for breast cancer the number of tested drugs and targeted pathways have increased immensely. In addition, the introduction of imm |
|---|---|
| Beschreibung: | Gesehen am 10.07.2019 |
| Beschreibung: | Online Resource |
| ISSN: | 1473-656X |
| DOI: | 10.1097/GCO.0000000000000510 |